针对Ⅲ期非小细胞肺癌的治愈导向还是关怀导向治疗方案？ - Suppr | 超能文献

Cure- or care-oriented regimen for stage III non-small-cell lung cancer?

作者信息

Hotta Katsuyuki, Nagio Takigawa, Matsuo Keitaro, Kiura Katsuyuki

出版信息

J Clin Oncol. 2011 Apr 10;29(11):e320. doi: 10.1200/JCO.2010.32.6025. Epub 2011 Mar 14.

DOI:10.1200/JCO.2010.32.6025

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cure- or care-oriented regimen for stage III non-small-cell lung cancer?针对Ⅲ期非小细胞肺癌的治愈导向还是关怀导向治疗方案？

J Clin Oncol. 2011 Apr 10;29(11):e320. doi: 10.1200/JCO.2010.32.6025. Epub 2011 Mar 14.

2

Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.术后辅助紫杉醇/卡铂及胸部放疗用于II期和IIIA期非小细胞肺癌切除患者的II期试验：放射肿瘤学组（RTOG）9705的长期结果令人鼓舞

J Clin Oncol. 2005 May 20;23(15):3480-7. doi: 10.1200/JCO.2005.12.120.

3

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.两种常用于局部晚期III期非小细胞肺癌的新辅助放化疗方案：长期结果及与病理反应的关联

J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13. doi: 10.1016/j.jtcvs.2003.07.027.

4

Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A/B) non-small cell lung cancer (NSCLC): a preliminary report.不可切除（大块型）Ⅲ期（A/B）非小细胞肺癌同步放化疗的Ⅱ期研究：初步报告

J Med Assoc Thai. 2000 Jan;83(1):85-92.

5

Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer.卡铂/紫杉醇/硼替佐米联合放化疗序贯手术切除治疗 III 期非小细胞肺癌的 I 期临床试验。

Lung Cancer. 2010 Apr;68(1):84-8. doi: 10.1016/j.lungcan.2009.05.003. Epub 2009 Jun 21.

6

Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.III 期非小细胞肺癌的三联疗法的 II 期临床试验：采用化疗作为诱导治疗，同期超分割放化疗联合卡铂和紫杉醇，随后进行手术切除：单中心研究。

J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25.

7

Combined modality therapy for stage III non-small-cell lung cancer.III 期非小细胞肺癌的联合治疗模式。

Semin Radiat Oncol. 2010 Jul;20(3):186-91. doi: 10.1016/j.semradonc.2010.01.007.

8

[Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].[每周紫杉醇与卡铂同步三维适形放疗治疗局部晚期非小细胞肺癌]

Zhonghua Zhong Liu Za Zhi. 2007 Oct;29(10):769-72.

9

[The results of combined treatment for stage III lung cancer including the use of intraoperative radiotherapy].[III期肺癌综合治疗的结果，包括术中放疗的应用]

Vopr Onkol. 2013;59(5):606-10.

10

[Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].[ⅢA期非小细胞肺癌（NSCLC）的治疗管理]

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S29-32.

引用本文的文献

1

Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.吉非替尼诱导联合放化疗用于表皮生长因子受体（EGFR）突变的Ⅲ期非小细胞肺癌的5年疗效：LOGIK0902/OLCSG0905Ⅱ期研究

Int J Clin Oncol. 2025 Mar;30(3):497-503. doi: 10.1007/s10147-025-02696-3. Epub 2025 Feb 5.

2

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: Emerging Mechanisms and Perspectives.免疫检查点抑制剂治疗不可切除的III期非小细胞肺癌：新出现的机制与展望

Lung Cancer (Auckl). 2019 Dec 31;10:161-170. doi: 10.2147/LCTT.S184380. eCollection 2019.